Yiftach Roth
Known title: Chief ScientistCIK: 0002111635
Associated companies
Transaction History
| BWAY | ▼ Sell | Open Market | 1,000 | — | 6/2/2026 | View on chart |
| BWAY | ▼ Sell | Open Market | 2,000 | — | 6/2/2026 | View on chart |
| BWAY | ▼ Sell | Open Market | 2,000 | — | 6/1/2026 | View on chart |
| BWAY | ▼ Sell | Open Market | 2,000 | — | 6/1/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
BrainsWay Reports Expansion of TMS Insurance Coverage
BrainsWay announced that favorable insurance coverage for its Accelerated Deep TMS technology has expanded to over 70 million covered lives. This development is relevant as it potentially broadens the patient base for the company's devices. The stock is currently trading near its 52-week low, with an RSI of 30.3 indicating oversold conditions.
BrainsWay Reports Expansion of TMS Insurance Coverage. BrainsWay announced that favorable insurance coverage for its Accelerated Deep TMS technology has expanded to over 70 million covered lives. This development is relevant as it potentially broadens the patient base for the company's devices. The stock is currently trading near its 52-week low, with an RSI of 30.3 indicating oversold conditions.